The Drug-Induced Respiratory Disease Website
Sometimes not specified otherwise
Publications
Kaneko T, Otoshi R, Sekine A, Baba T, Yamada C, Haga S, Tagami Y, Sawazumi T, Takemura T, Komatsu S, Hagiwara E, Ogura T
Drug-related pneumonitis caused by amikacin liposome inhalation suspension: One pathologically proven case and single-center experience.
Respiratory investigation 2024 Jul;62;513-516 — 2024 Jul — 513-516
Takao D, Takeda K, Takazono T, Ozasa M, Ito Y, Ashizawa N, Hirayama T, Iwanaga N, Takemoto S, Ide S, Tashiro M, Hosogaya N, Kido T, Sakamoto N, Obase Y, Okano S, Izumikawa K, Yanagihara K, Mukae H
A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2023 Aug;29;806-808 — 2023 Aug — 806-808
Liposomal Amikacin Inhalation Suspension-induced Pneumonitis.
Internal medicine (Tokyo, Japan) 2022 Feb 01;; — 2022 Feb 01